NCT00544349View on ClinicalTrials.gov

Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2011

Conditions

Colorectal CancerMetastatic Cancer

Interventions

BIOLOGICAL

cetuximab

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (7)

14076

Centre Regional Francois Baclesse, Caen

21079

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

33075

Hopital Saint Andre, Bordeaux

35062

Centre Eugene Marquis, Rennes

75651

CHU Pitie-Salpetriere, Paris

94804

Hopital Paul Brousse, Villejuif

F-94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors

lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT00544349 - Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter